Delivery Order SPE2DB24D1205-SPE2DB25FCXRG
Award Date
6/12/25
Potential Completion Date
6/13/25
Potential Value
$5.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,079.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,076,036 units of the medication Vyvanse 40 mg capsules. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 30, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award is for the delivery of 4,565,153,938 units of Vyvanse 40 mg capsules to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, on a firm fixed-price basis with a ceiling value of $6,580.88. The contract has a period of performance through July 16, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,712.40 firm fixed-price delivery order is for 4,568,202,512 units of the prescription medication Vyvanse 30 mg capsule. The contract has an ultimate completion date of May 12, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA...
This federal contract award, valued at $1,337.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the provision of 4,568,013,823 units of the prescription medication Vyvanse 30 mg capsules. The contract has an ultimate completion date of April 24, 2025 and is a firm fixed price arrangement. It is not designated as a set-aside contract, indicating open...
This federal contract award, valued at $2,988.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order (SPE2DB20D1100|SPE2DB25FB6B4) for the supply of 4,567,850,772 units of the medication Vyvanse 40 mg capsules. The contract has an ultimate completion date of April 9, 2025 and is a firm fixed-price, non-set-aside contract. Amerisourcebergen Drug Corp holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,991.21, is a delivery order for 4,566,373,534 units of the medication Vyvanse 40 mg capsules. The contract has a firm fixed price and an ultimate completion date of November 8, 2024. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,685.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,008,658 units of the prescription medication Vyvanse 40 mg capsules. The award is not designated as a set-aside contract, indicating open competition. It is a delivery order contract with a firm fixed-price pricing type, with an ultimate completion date...
This federal contract award was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,603.51, is for the delivery of 4,563,308,982 units of the medication Vyvanse 40 mg capsules. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 12, 2024. No set-aside designation was used for this award. Amerisourcebergen...
This federal contract award, valued at $2,670.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,058,061 units of the medication Vyvanse 40 mg capsules. The contract has an ultimate completion date of April 29, 2025 and is a firm fixed-price contract. This contract award is not associated with a set-aside program. Amerisourcebergen...
The U.S. Defense Logistics Agency (DLA) has awarded a firm-fixed-price delivery order contract valued at $1,210.55 to AmerisourceBergen Drug Corp for the supply of 4,566,110,813 units of the prescription drug Vyvanse 40 mg capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that the DLA Troop Support Medical has with AmerisourceBergen, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military...